Patent ID: 11877995
Assignee: IMMUNIC AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 0:
1. A method of treating multiple sclerosis in a subject in need thereof, the method comprising:
a) administering to the subject at least one compound each day for 5 to 10 days at an initial daily dose of about 14 μmol to about 130 μmol per day; and thereafter
b) administering to the subject the at least one compound at a subsequent daily dose,
wherein the subsequent daily dose is 1.5 to 8-fold higher than the initial daily dose, and
wherein the at least one compound includes 2-({3-fluoro-3′-methoxy-[1,1′-biphenyl]-4-yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid or a pharmaceutically-acceptable salt or solvate thereof.